Abstract
FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have